LinLin Qian Form 3 Health In Tech / LinLin Qian ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Qian LinLin

(Last) (First) (Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/20/2024

3. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	7,800,000	D
Class A Common Stock	82,670(1)	D
Class A Common Stock	82,500(2)	D
Class A Common Stock	56,385(3)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(4)	(4)	Class A Common Stock	2,700,000	(4)	D
Stock Options	(5)	07/01/2028	Class A Common Stock	495,000	0.71	D
Stock Options	(6)	07/01/2028	Class A Common Stock	170,115	0.71	D
Stock Options	(7)	07/01/2028	Class A Common Stock	46,395	0.71	D

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.

2. Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.

3. Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The Restricted Stock vest over three years, with one-third of the Restricted Stock vesting upon the closing of the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.

4. Each share of Class B Common Stock is entitled to ten votes and is convertible at any time into one share of Class A Common Stock for no additional consideration.

5. Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest six months after the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.

6. Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest over three years, with one-third of the options vesting upon the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.

7. Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.

	/s/ LinLin Qian	12/20/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.